Packaged Foods
Compare Stocks
5 / 10Stock Comparison
JBSS vs FRPT vs SMPL vs ANDE vs IPAR
Revenue, margins, valuation, and 5-year total return — side by side.
Packaged Foods
Packaged Foods
Food Distribution
Household & Personal Products
JBSS vs FRPT vs SMPL vs ANDE vs IPAR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Packaged Foods | Packaged Foods | Packaged Foods | Food Distribution | Household & Personal Products |
| Market Cap | $913M | $2.74B | $1.24B | $2.41B | $3.01B |
| Revenue (TTM) | $1.14B | $1.14B | $1.45B | $10.98B | $1.49B |
| Net Income (TTM) | $70M | $200M | $91M | $129M | $201M |
| Gross Margin | 19.1% | 38.9% | 34.0% | 6.6% | 64.0% |
| Operating Margin | 8.9% | 8.8% | 14.4% | 1.1% | 18.0% |
| Forward P/E | 10.7x | 41.1x | 7.5x | 14.5x | 19.4x |
| Total Debt | $102M | $560M | $304M | $1.04B | $224M |
| Cash & Equiv. | $585K | $278M | $98M | $98M | $158M |
JBSS vs FRPT vs SMPL vs ANDE vs IPAR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| John B. Sanfilippo … (JBSS) | 100 | 89.8 | -10.2% |
| Freshpet, Inc. (FRPT) | 100 | 72.4 | -27.6% |
| The Simply Good Foo… (SMPL) | 100 | 73.0 | -27.0% |
| The Andersons, Inc. (ANDE) | 100 | 546.4 | +446.4% |
| Inter Parfums, Inc. (IPAR) | 100 | 202.5 | +102.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: JBSS vs FRPT vs SMPL vs ANDE vs IPAR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
JBSS ranks third and is worth considering specifically for stability.
- Beta 0.31 vs FRPT's 0.91, lower leverage
FRPT has the current edge in this matchup, primarily because of its strength in growth exposure.
- Rev growth 13.0%, EPS growth 183.9%, 3Y rev CAGR 22.8%
- 13.0% revenue growth vs ANDE's -2.2%
- 17.6% margin vs ANDE's 1.2%
SMPL is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.38, Low D/E 16.8%, current ratio 3.64x
- Lower P/E (7.5x vs 19.4x), PEG 0.31 vs 0.57
ANDE is the clearest fit if your priority is valuation efficiency.
- PEG 0.22 vs JBSS's 7.58
- +127.2% vs SMPL's -64.8%
IPAR is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.
- Dividend streak 5 yrs, beta 0.54, yield 3.4%
- 255.2% 10Y total return vs ANDE's 192.1%
- Beta 0.54, yield 3.4%, current ratio 2.99x
- 3.4% yield, 5-year raise streak, vs ANDE's 1.1%, (2 stocks pay no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 13.0% revenue growth vs ANDE's -2.2% | |
| Value | Lower P/E (7.5x vs 19.4x), PEG 0.31 vs 0.57 | |
| Quality / Margins | 17.6% margin vs ANDE's 1.2% | |
| Stability / Safety | Beta 0.31 vs FRPT's 0.91, lower leverage | |
| Dividends | 3.4% yield, 5-year raise streak, vs ANDE's 1.1%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +127.2% vs SMPL's -64.8% | |
| Efficiency (ROA) | 12.9% ROA vs ANDE's 3.6%, ROIC 18.6% vs 4.6% |
JBSS vs FRPT vs SMPL vs ANDE vs IPAR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
JBSS vs FRPT vs SMPL vs ANDE vs IPAR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
FRPT leads in 1 of 6 categories
SMPL leads 1 • IPAR leads 1 • ANDE leads 1 • JBSS leads 1 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
FRPT leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ANDE is the larger business by revenue, generating $11.0B annually — 9.7x FRPT's $1.1B. FRPT is the more profitable business, keeping 17.6% of every revenue dollar as net income compared to ANDE's 1.2%. On growth, FRPT holds the edge at +13.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.1B | $1.1B | $1.4B | $11.0B | $1.5B |
| EBITDAEarnings before interest/tax | $127M | $165M | $231M | $218M | $291M |
| Net IncomeAfter-tax profit | $70M | $200M | $91M | $129M | $201M |
| Free Cash FlowCash after capex | $33M | $223M | $174M | -$105M | $199M |
| Gross MarginGross profit ÷ Revenue | +19.1% | +38.9% | +34.0% | +6.6% | +64.0% |
| Operating MarginEBIT ÷ Revenue | +8.9% | +8.8% | +14.4% | +1.1% | +18.0% |
| Net MarginNet income ÷ Revenue | +6.2% | +17.6% | +6.3% | +1.2% | +13.5% |
| FCF MarginFCF ÷ Revenue | +2.9% | +19.6% | +12.0% | -1.0% | +13.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +4.6% | +13.1% | -0.3% | -1.2% | +1.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +31.9% | +4.5% | -31.6% | +96.0% | +2.3% |
Valuation Metrics
SMPL leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 12.2x trailing earnings, SMPL trades at a 52% valuation discount to ANDE's 25.3x P/E. Adjusting for growth (PEG ratio), ANDE offers better value at 0.39x vs JBSS's 11.02x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $913M | $2.7B | $1.2B | $2.4B | $3.0B |
| Enterprise ValueMkt cap + debt − cash | $1.0B | $3.0B | $1.4B | $3.4B | $3.1B |
| Trailing P/EPrice ÷ TTM EPS | 15.53x | 21.16x | 12.20x | 25.29x | 17.93x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.68x | 41.11x | 7.45x | 14.50x | 19.38x |
| PEG RatioP/E ÷ EPS growth rate | 11.02x | — | 0.51x | 0.39x | 0.53x |
| EV / EBITDAEnterprise value multiple | 8.73x | 16.62x | 5.97x | 12.82x | 11.33x |
| Price / SalesMarket cap ÷ Revenue | 0.82x | 2.49x | 0.86x | 0.22x | 2.02x |
| Price / BookPrice ÷ Book value/share | 2.54x | 2.59x | 0.70x | 1.88x | 2.74x |
| Price / FCFMarket cap ÷ FCF | — | 221.45x | 7.86x | — | 15.80x |
Profitability & Efficiency
IPAR leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
JBSS delivers a 19.5% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $5 for SMPL. SMPL carries lower financial leverage with a 0.17x debt-to-equity ratio, signaling a more conservative balance sheet compared to ANDE's 0.81x. On the Piotroski fundamental quality scale (0–9), FRPT scores 6/9 vs JBSS's 2/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +19.5% | +17.0% | +5.2% | +9.5% | +18.4% |
| ROA (TTM)Return on assets | +11.7% | +11.4% | +3.7% | +3.6% | +12.9% |
| ROICReturn on invested capital | +15.2% | +5.3% | +8.1% | +4.6% | +18.6% |
| ROCEReturn on capital employed | +20.4% | +6.0% | +9.4% | +5.8% | +23.3% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 6 | 5 | 6 | 4 |
| Debt / EquityFinancial leverage | 0.28x | 0.46x | 0.17x | 0.81x | 0.20x |
| Net DebtTotal debt minus cash | $102M | $282M | $206M | $945M | $66M |
| Cash & Equiv.Liquid assets | $585,000 | $278M | $98M | $98M | $158M |
| Total DebtShort + long-term debt | $102M | $560M | $304M | $1.0B | $224M |
| Interest CoverageEBIT ÷ Interest expense | 26.02x | 13.29x | 6.77x | 3.21x | 50.40x |
Total Returns (Dividends Reinvested)
ANDE leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ANDE five years ago would be worth $24,161 today (with dividends reinvested), compared to $3,165 for FRPT. Over the past 12 months, ANDE leads with a +127.2% total return vs SMPL's -64.8%. The 3-year compound annual growth rate (CAGR) favors ANDE at 25.4% vs SMPL's -31.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +14.1% | -7.1% | -36.4% | +34.2% | +10.9% |
| 1-Year ReturnPast 12 months | +39.3% | -31.1% | -64.8% | +127.2% | -18.8% |
| 3-Year ReturnCumulative with dividends | -22.9% | -17.4% | -67.8% | +97.0% | -32.7% |
| 5-Year ReturnCumulative with dividends | +4.0% | -68.4% | -64.3% | +141.6% | +41.9% |
| 10-Year ReturnCumulative with dividends | +101.1% | +517.3% | +3.7% | +192.1% | +255.2% |
| CAGR (3Y)Annualised 3-year return | -8.3% | -6.2% | -31.5% | +25.4% | -12.4% |
Risk & Volatility
JBSS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
JBSS is the less volatile stock with a 0.31 beta — it tends to amplify market swings less than FRPT's 0.91 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JBSS currently trades 91.7% from its 52-week high vs SMPL's 33.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.31x | 0.91x | 0.38x | 0.55x | 0.54x |
| 52-Week HighHighest price in past year | $85.15 | $89.80 | $36.92 | $82.11 | $142.61 |
| 52-Week LowLowest price in past year | $58.47 | $46.76 | $10.21 | $31.03 | $77.21 |
| % of 52W HighCurrent price vs 52-week peak | +91.7% | +62.2% | +33.7% | +86.2% | +65.9% |
| RSI (14)Momentum oscillator 0–100 | 49.2 | 29.1 | 42.9 | 35.0 | 55.9 |
| Avg Volume (50D)Average daily shares traded | 80K | 1.5M | 2.8M | 333K | 259K |
Analyst Outlook
Evenly matched — ANDE and IPAR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: JBSS as "Buy", FRPT as "Buy", SMPL as "Buy", ANDE as "Buy", IPAR as "Hold". Consensus price targets imply 62.1% upside for SMPL (target: $20) vs 5.9% for ANDE (target: $75). For income investors, IPAR offers the higher dividend yield at 3.40% vs ANDE's 1.11%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $73.42 | $20.17 | $75.00 | $107.50 |
| # AnalystsCovering analysts | 2 | 29 | 24 | 20 | 19 |
| Dividend YieldAnnual dividend ÷ price | +2.7% | — | — | +1.1% | +3.4% |
| Dividend StreakConsecutive years of raises | 0 | — | — | 23 | 5 |
| Dividend / ShareAnnual DPS | $2.08 | — | — | $0.79 | $3.20 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | 0.0% | +4.1% | +0.6% | +0.5% |
FRPT leads in 1 of 6 categories (Income & Cash Flow). SMPL leads in 1 (Valuation Metrics). 1 tied.
JBSS vs FRPT vs SMPL vs ANDE vs IPAR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is JBSS or FRPT or SMPL or ANDE or IPAR a better buy right now?
For growth investors, Freshpet, Inc.
(FRPT) is the stronger pick with 13. 0% revenue growth year-over-year, versus -2. 2% for The Andersons, Inc. (ANDE). The Simply Good Foods Company (SMPL) offers the better valuation at 12. 2x trailing P/E (7. 5x forward), making it the more compelling value choice. Analysts rate John B. Sanfilippo & Son, Inc. (JBSS) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — JBSS or FRPT or SMPL or ANDE or IPAR?
On trailing P/E, The Simply Good Foods Company (SMPL) is the cheapest at 12.
2x versus The Andersons, Inc. at 25. 3x. On forward P/E, The Simply Good Foods Company is actually cheaper at 7. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: The Andersons, Inc. wins at 0. 22x versus John B. Sanfilippo & Son, Inc. 's 7. 58x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — JBSS or FRPT or SMPL or ANDE or IPAR?
Over the past 5 years, The Andersons, Inc.
(ANDE) delivered a total return of +141. 6%, compared to -68. 4% for Freshpet, Inc. (FRPT). Over 10 years, the gap is even starker: FRPT returned +517. 3% versus SMPL's +3. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — JBSS or FRPT or SMPL or ANDE or IPAR?
By beta (market sensitivity over 5 years), John B.
Sanfilippo & Son, Inc. (JBSS) is the lower-risk stock at 0. 31β versus Freshpet, Inc. 's 0. 91β — meaning FRPT is approximately 191% more volatile than JBSS relative to the S&P 500. On balance sheet safety, The Simply Good Foods Company (SMPL) carries a lower debt/equity ratio of 17% versus 81% for The Andersons, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — JBSS or FRPT or SMPL or ANDE or IPAR?
By revenue growth (latest reported year), Freshpet, Inc.
(FRPT) is pulling ahead at 13. 0% versus -2. 2% for The Andersons, Inc. (ANDE). On earnings-per-share growth, the picture is similar: Freshpet, Inc. grew EPS 183. 9% year-over-year, compared to -26. 1% for The Simply Good Foods Company. Over a 3-year CAGR, FRPT leads at 22. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — JBSS or FRPT or SMPL or ANDE or IPAR?
Freshpet, Inc.
(FRPT) is the more profitable company, earning 12. 6% net margin versus 0. 9% for The Andersons, Inc. — meaning it keeps 12. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IPAR leads at 18. 2% versus 1. 2% for ANDE. At the gross margin level — before operating expenses — IPAR leads at 63. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is JBSS or FRPT or SMPL or ANDE or IPAR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, The Andersons, Inc. (ANDE) is the more undervalued stock at a PEG of 0. 22x versus John B. Sanfilippo & Son, Inc. 's 7. 58x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, The Simply Good Foods Company (SMPL) trades at 7. 5x forward P/E versus 41. 1x for Freshpet, Inc. — 33. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SMPL: 62. 1% to $20. 17.
08Which pays a better dividend — JBSS or FRPT or SMPL or ANDE or IPAR?
In this comparison, IPAR (3.
4% yield), JBSS (2. 7% yield), ANDE (1. 1% yield) pay a dividend. FRPT, SMPL do not pay a meaningful dividend and should not be held primarily for income.
09Is JBSS or FRPT or SMPL or ANDE or IPAR better for a retirement portfolio?
For long-horizon retirement investors, John B.
Sanfilippo & Son, Inc. (JBSS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 31), 2. 7% yield, +101. 1% 10Y return). Both have compounded well over 10 years (JBSS: +101. 1%, FRPT: +517. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between JBSS and FRPT and SMPL and ANDE and IPAR?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: JBSS is a small-cap deep-value stock; FRPT is a small-cap quality compounder stock; SMPL is a small-cap deep-value stock; ANDE is a small-cap quality compounder stock; IPAR is a small-cap deep-value stock. JBSS, ANDE, IPAR pay a dividend while FRPT, SMPL do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.